Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMART03: Continuous valproic acid in childhood-onset spinal muscular atrophy
jRCT2091220259Recruiting
- Sponsor
- Institute of Medical Genetics, Tokyo Women's Medical University
- Start
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of valproic acid in spinal muscular atrophy (SMA), sponsored by Institute of Medical Genetics, Tokyo Women's Medical University. Primary endpoint: HFMSE score (primary). Started Aug 2016; status: recruiting.
02
Drugs
valproic acid
03
Conditions
spinal muscular atrophy (SMA)
Beyond the preview
Go deeper on jRCT2091220259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2091220259.